Skin disorders in diabetes mellitus;Hauterkrankungen bei diabetes mellitus

JDDG - Journal of the German Society of Dermatology

Volumn 12, Issue 10, 2014, Pages 847-864

  Gkogkolou, Paraskevi ^a   Böhm, Markus ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ACANTHOSIS NIGRICANS; ARTICLE; BACTERIAL SKIN DISEASE; BINKLEY SYNDROME; CANDIDIASIS; CHARCOT FOOT; DIABETES MELLITUS; DIABETIC BULLAE; DIABETIC CHEIROARTHROPATHY; DIABETIC ERYTHEMA; DIABETIC FOOT; DIABETIC PRURITUS; DIABETIC PURPURA; DRUG HYPERSENSITIVITY; EXTERNAL OTITIS; GRANULOMA ANNULARE; HAIR AN SYNDROME; HUMAN; INJECTION SITE REACTION; LIPODYSTROPHY; NECROBIOSIS LIPOIDICA; PATHOPHYSIOLOGY; SCLEREDEMA; SKIN DEFECT; SKIN DISEASE; SKIN INFECTION; VITILIGO; DIABETES COMPLICATIONS; RISK FACTOR; SKIN DISEASES; SKIN NEOPLASMS;

DIABETES COMPLICATIONS; HUMANS; RISK FACTORS; SKIN DISEASES; SKIN NEOPLASMS;

EID: 84933053644     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12424     Document Type: Article

References (25)

1. Behm B, Schreml S, Landthaler M, Babilas P. Skin signs in diabetes mellitus. J Eur Acad Dermatol Venereol 2012; 26: 1203-11.
2. Ahmed I, Goldstein B. Diabetes mellitus. Clin Dermatol 2006; 24: 237-46.
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37 Suppl 1: S81-90.
4. Köster I, Huppertz E, Hauner H, Schubert I. Direct costs of diabetes mellitus in Germany - CoDiM 2000-2007. Exp Clin Endocrinol Diabetes 2011; 119: 377-85.
5. Blakytny R, Jude EB. Altered molecular mechanisms of diabetic foot ulcers. Int J Low Extrem Wounds 2009; 8: 95-104.
6. Gkogkolou P, Böhm M. Advanced glycation end products: Key players in skin aging? Dermatoendocrinol 2012; 4: 259-70.
7. Karrer S. Diabetic foot syndrome. Hautarzt 2011; 62: 493-503.
8. Lobmann R. Das diabetische Fußsyndrom. Internist 2011; 52: 539-48.
9. Prompers L, Huijberts M, Schaper N et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia 2008; 51: 1826-34.
10. O'Loughlin A, McIntosh C, Dinneen SF, O'Brien T. Review paper: basic concepts to novel therapies: a review of the diabetic foot. Int J Low Extrem Wounds 2010; 9: 90-102.
11. Rogers LC, Frykberg RG, Armstrong DG et al. The Charcot foot in diabetes. Diabetes Care 2011; 34: 2123-9.
12. Suaya JA, Eisenberg DF, Fang C, Miller LG. Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S. PLoS One 2013; 8: e60057.
13. Oumeish OY. Skin disorders in patients with diabetes. Clin Dermatol 2008; 26: 235-42.
14. Morgan AJ, Schwartz RA. Diabetic dermopathy: A subtle sign with grave implications. J Am Acad Dermatol 2008; 58: 447-51.
15. Reid SD, Ladizinski B, Lee K et al. Update on necrobiosis lipoidica: A review of etiology, diagnosis, and treatment options. J Am Acad Dermatol 2013; 69: 783-91.
16. Kreuter A, Knierim C, Stücker et al. Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study. Br J Dermatol. 2005; 153: 802-7.
17. Kowalzick L. Granuloma annulare. Hautarzt 2005; 56: 1071-81.
18. Meguerditchian C, Jacquet P, Béliard S et al. Scleredema adultorum of Buschke: an under recognized skin complication of diabetes. Diabetes Metab 2006; 32: 481-4.
19. Cherqaoui R, McKenzie S, Nunlee-Bland G. Diabetic cheiroarthropathy: a case report and review of the literature. Case Rep Endocrinol 2013; 1-3.
20. Higgins SP, Freemark M, Prose NS. Acanthosis nigricans: a practical approach to evaluation and management. Dermatol Online J 2008; 14: 2.
21. Ständer S, Darsow U, Mettang T et al. S2k guideline. Chronic Pruritus. J Dtsch Dermatol Ges 2012; 10 Suppl 4: S1-27.
22. Stumpf A, Ständer S. Neuropathic itch: diagnosis and management. Dermatol Ther 2013; 26: 104-9.
23. Taieb A, Alomar A, Böhm M et al. Vitiligo European Task Force (VETF); European Academy of Dermatology and Venereology (EADV); Union Européenne des Médecins Spécialistes (UEMS). Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol 2013; 168: 5-19.
24. Amerio P, Tracanna M, De Remigis P et al. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4. Clin Exp Dermatol 2006; 31: 746-9.
25. Rager KM, Omar HA. Androgen excess disorders in women: the severe insulin-resistant hyperandrogenic syndrome, HAIR-AN. ScientificWorldJournal 2006; 6: 116-21.